Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Thorac Oncol. 2017 Jan 11;12(5):884–889. doi: 10.1016/j.jtho.2017.01.006

Figure 2. Computed tomography (CT) scans of a NSCLC patient exhibiting primary resistance to erlotinib and subsequent response to afatinib.

Figure 2

Coronal and transverse CT scan images at baseline before treatment, after two months of erlotinib treatment, and after two months of afatinib treatment.